Breaking News Instant updates and real-time market news.

IBDRY

Iberdrola

$0.00 /

+ (+0.00%)

20:24
05/25/20
05/25
20:24
05/25/20
20:24

Iberdrola upgraded to Buy from Neutral at Goldman Sachs

Goldman Sachs analyst Alberto Gandolfi upgraded Iberdrola to Buy from Neutral with a price target of EUR 10, up from EUR 9.75. Although the recent drop in power prices and the deprecation of key currencies will limit earnings growth to 2023, the company's portfolio by then should be 90% composed of fully regulated networks, renewables and contracted generation, which offer high quality earnings, Gandolfi tells investors in a research note. As such, the analyst expects Iberdrola to close the valuation gap to its fully regulated peers.

IBDRY Iberdrola
$0.00 /

+ (+0.00%)

04/09/20 Oddo BHF
Iberdrola upgraded to Buy from Neutral at Oddo BHF
04/07/20 RBC Capital
Iberdrola downgraded to Sector Perform from Outperform at RBC Capital
04/07/20 UBS
National Grid, Iberdrola upgraded to Buy; Centrica, Engie cut to Neutral at UBS
04/07/20 UBS
Iberdrola upgraded to Buy from Neutral at UBS

TODAY'S FREE FLY STORIES

Syndicate
nCino indicated to open at $66, IPO priced at $31  11:10
07/14/20
07/14
11:10
07/14/20
11:10
NCNO

nCino

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 14
    Jul
NCNO nCino
$0.00 /

+ (+0.00%)

General news
FX Action: USD-CAD » 11:10
07/14/20
07/14
11:10
07/14/20
11:10

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

On The Fly
UBS says sell Spotify with podcasting future seen as 'more than priced in' » 11:09
07/14/20
07/14
11:09
07/14/20
11:09
SPOT

Spotify

$257.25 /

-3.86 (-1.48%)

Shares of Spotify (SPOT)…

Open Full Text

ShowHide Related Items >><<
SPOT Spotify
$257.25 /

-3.86 (-1.48%)

SPOT Spotify
$257.25 /

-3.86 (-1.48%)

10:11 Today
Fly Intel: Top five analyst downgrades
06:24 Today UBS
Spotify double-downgraded to Sell from Buy at UBS
06:13 Today UBS
Spotify downgraded to Sell from Buy at UBS
07/13/20 BofA
Spotify price target raised to $357 from $185 at BofA
SPOT Spotify
$257.25 /

-3.86 (-1.48%)

SPOT Spotify
$257.25 /

-3.86 (-1.48%)

SPOT Spotify
$257.25 /

-3.86 (-1.48%)

SPOT Spotify
$257.25 /

-3.86 (-1.48%)

Recommendations
Intertape Polymer price target raised to C$17.50 from C$17 at Scotiabank » 11:09
07/14/20
07/14
11:09
07/14/20
11:09
ITPOF

Intertape Polymer

$0.00 /

+ (+0.00%)

Scotiabank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITPOF Intertape Polymer
$0.00 /

+ (+0.00%)

ITPOF Intertape Polymer
$0.00 /

+ (+0.00%)

07/09/20 Scotiabank
Intertape Polymer price target raised to C$17 from C$16.50 at Scotiabank
05/14/20 Scotiabank
Intertape Polymer price target lowered to C$16.50 from C$17 at Scotiabank
05/14/20 TD Securities
Intertape Polymer price target lowered to C$8 from C$8.50 at TD Securities
05/14/20 CIBC
Intertape Polymer price target raised to C$12.50 from C$11 at CIBC
ITPOF Intertape Polymer
$0.00 /

+ (+0.00%)

Hot Stocks
Wells Fargo to begin to take 'decisive actions' on costs, says CEO Scharf  11:08
07/14/20
07/14
11:08
07/14/20
11:08
WFC

Wells Fargo

$23.90 /

-1.53 (-6.02%)

 
ShowHide Related Items >><<
WFC Wells Fargo
$23.90 /

-1.53 (-6.02%)

WFC Wells Fargo
$23.90 /

-1.53 (-6.02%)

07/10/20 Baird
Wells Fargo upgraded to Outperform from Neutral at Baird
07/09/20 Wolfe Research
Wells Fargo upgraded to Peer Perform from Underperform at Wolfe Research
07/08/20 JPMorgan
Wells Fargo price target lowered to $29.50 from $32 at JPMorgan
07/08/20 Seaport Global
Wells Fargo initiated with a Neutral at Seaport Global
WFC Wells Fargo
$23.90 /

-1.53 (-6.02%)

WFC Wells Fargo
$23.90 /

-1.53 (-6.02%)

WFC Wells Fargo
$23.90 /

-1.53 (-6.02%)

WFC Wells Fargo
$23.90 /

-1.53 (-6.02%)

General news
4-Week Bill Announcement Offering Amount data reported » 11:07
07/14/20
07/14
11:07
07/14/20
11:07

4-Week Bill Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
8-Week Bill Announcement Offering Amount data reported » 11:07
07/14/20
07/14
11:07
07/14/20
11:07

8-Week Bill Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Wells Fargo CEO: Asset cap limits ability to offset low rates » 11:06
07/14/20
07/14
11:06
07/14/20
11:06
WFC

Wells Fargo

$23.82 /

-1.61 (-6.33%)

Comments taken from Q2…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WFC Wells Fargo
$23.82 /

-1.61 (-6.33%)

WFC Wells Fargo
$23.82 /

-1.61 (-6.33%)

07/10/20 Baird
Wells Fargo upgraded to Outperform from Neutral at Baird
07/09/20 Wolfe Research
Wells Fargo upgraded to Peer Perform from Underperform at Wolfe Research
07/08/20 JPMorgan
Wells Fargo price target lowered to $29.50 from $32 at JPMorgan
07/08/20 Seaport Global
Wells Fargo initiated with a Neutral at Seaport Global
WFC Wells Fargo
$23.82 /

-1.61 (-6.33%)

WFC Wells Fargo
$23.82 /

-1.61 (-6.33%)

WFC Wells Fargo
$23.82 /

-1.61 (-6.33%)

WFC Wells Fargo
$23.82 /

-1.61 (-6.33%)

Hot Stocks
Provident Bancorp rebrands to BankProv » 11:05
07/14/20
07/14
11:05
07/14/20
11:05
PVBC

Provident Bancorp

$7.85 /

+ (+0.00%)

The Provident Bank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PVBC Provident Bancorp
$7.85 /

+ (+0.00%)

PVBC Provident Bancorp
$7.85 /

+ (+0.00%)

03/04/20 Compass Point
Compass Point downgrades Provident Bancorp as COVID-19 hits bond yields
03/04/20 Compass Point
Provident Bancorp downgraded to Neutral from Buy at Compass Point
10/18/19 Compass Point
Provident Bancorp initiated with a Buy at Compass Point
Hot Stocks
Boeing reports Q2 commercial, defense deliveries » 11:04
07/14/20
07/14
11:04
07/14/20
11:04
BA

Boeing

$178.60 /

+2.98 (+1.70%)

The Boeing Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BA Boeing
$178.60 /

+2.98 (+1.70%)

BA Boeing
$178.60 /

+2.98 (+1.70%)

07/09/20
Emirates tells Bloomberg Boeing 777X likely to miss 2021 debut
07/08/20 Bernstein
Bernstein downgrades Spirit AeroSystems on slower delivery recovery
06/26/20
Fly Intel: Top five analyst downgrades
06/26/20 RBC Capital
Spirit AeroSystems initiated with an Outperform at RBC Capital
BA Boeing
$178.60 /

+2.98 (+1.70%)

BA Boeing
$178.60 /

+2.98 (+1.70%)

BA Boeing
$178.60 /

+2.98 (+1.70%)

BA Boeing
$178.60 /

+2.98 (+1.70%)

Recommendations
Cytokinetics price target raised to $33 from $28 at Piper Sandler » 11:03
07/14/20
07/14
11:03
07/14/20
11:03
CYTK

Cytokinetics

$25.39 /

+1.24 (+5.13%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYTK Cytokinetics
$25.39 /

+1.24 (+5.13%)

CYTK Cytokinetics
$25.39 /

+1.24 (+5.13%)

07/10/20 Raymond James
Cytokinetics initiated with a Strong Buy at Raymond James
07/10/20 Raymond James
Cytokinetics initiated with a Strong Buy at Raymond James
07/07/20 Morgan Stanley
Cytokinetics price target raised to $35 from $29 at Morgan Stanley
05/11/20 H.C. Wainwright
Cytokinetics price target raised to $35 from $30 at H.C. Wainwright
CYTK Cytokinetics
$25.39 /

+1.24 (+5.13%)

CYTK Cytokinetics
$25.39 /

+1.24 (+5.13%)

Hot Stocks
Moderna Phase 3 COVID trial hits ClinicalTrials.gov with July 27 start » 11:03
07/14/20
07/14
11:03
07/14/20
11:03
MRNA

Moderna

$72.19 /

+0.47 (+0.66%)

ClinicalTrials.gov this…

ClinicalTrials.gov this morning posted Moderna's Phase 3 clinical trial for its mRNA-1273 vaccine being developed to prevent COVID-19. The study is designed to primarily evaluate the efficacy, safety, and immunogenicity of mRNA-1273 to prevent COVID-19 for up to two years after the second dose of mRNA-1273, according to the post. The study will include 3,000 participants and is expected to start on July 27, 2020. The estimated primary completion date is October 27, 2022. Shares of Moderna are up 68c to $72.46 in morning trading. Reference Link

ShowHide Related Items >><<
MRNA Moderna
$72.19 /

+0.47 (+0.66%)

MRNA Moderna
$72.19 /

+0.47 (+0.66%)

10:56 Today Piper Sandler
Moderna COVID vaccine trial on track for July start, says Piper Sandler
07/13/20 Brookline
Moderna initiated with a Buy at Brookline
07/13/20 Jefferies
Jefferies starts Moderna with Buy rating, $90 price target
07/08/20 Piper Sandler
Piper reiterates $100 target on Moderna after Phase II study enrolled
MRNA Moderna
$72.19 /

+0.47 (+0.66%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$72.19 /

+0.47 (+0.66%)

MRNA Moderna
$72.19 /

+0.47 (+0.66%)

MRNA Moderna
$72.19 /

+0.47 (+0.66%)

Recommendations
Briefing docs suggest AdComm 'challenges' for Mallinckrodt, says BMO Capital » 11:01
07/14/20
07/14
11:01
07/14/20
11:01
MNK

Mallinckrodt

$2.61 /

-0.055 (-2.06%)

BMO Capital analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNK Mallinckrodt
$2.61 /

-0.055 (-2.06%)

MNK Mallinckrodt
$2.61 /

-0.055 (-2.06%)

06/17/20 Citi
Sell Mallinckrodt, buy Endo with opioid risk coming back, says Citi
05/19/20 JPMorgan
Mallinckrodt downgraded to Underweight on unclear turnaround at JPMorgan
05/19/20 JPMorgan
Mallinckrodt downgraded to Underweight from Neutral at JPMorgan
04/24/20
Fly Intel: Top five analyst initiations
MNK Mallinckrodt
$2.61 /

-0.055 (-2.06%)

MNK Mallinckrodt
$2.61 /

-0.055 (-2.06%)

MNK Mallinckrodt
$2.61 /

-0.055 (-2.06%)

MNK Mallinckrodt
$2.61 /

-0.055 (-2.06%)

Options
Put volume 5x normal in Consumer Discretionary ETF as earnings season begins » 11:00
07/14/20
07/14
11:00
07/14/20
11:00
XLY

Consumer Discretionary Sector SPDR

$131.90 /

+0.3 (+0.23%)

Put volume 5x normal in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLY Consumer Discretionary Sector SPDR
$131.90 /

+0.3 (+0.23%)

03/18/20
Jefferies ups Health Care to Overweight, cuts Discretionary to Underweight
XLY Consumer Discretionary Sector SPDR
$131.90 /

+0.3 (+0.23%)

Hot Stocks
Citi CEO: Consumers were in 'pretty good shape' before pandemic  10:58
07/14/20
07/14
10:58
07/14/20
10:58
C

Citi

$51.60 /

-0.65 (-1.24%)

 
ShowHide Related Items >><<
C Citi
$51.60 /

-0.65 (-1.24%)

C Citi
$51.60 /

-0.65 (-1.24%)

07/08/20 Seaport Global
Citi initiated with a Buy at Seaport Global
07/07/20 Societe Generale
Societe Generale upgrades BofA, Citi to Buy on 'path to respectability'
07/07/20 Societe Generale
Citi upgraded to Buy from Hold at Societe Generale
07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
C Citi
$51.60 /

-0.65 (-1.24%)

C Citi
$51.60 /

-0.65 (-1.24%)

C Citi
$51.60 /

-0.65 (-1.24%)

C Citi
$51.60 /

-0.65 (-1.24%)

Recommendations
Moderna COVID vaccine trial on track for July start, says Piper Sandler » 10:56
07/14/20
07/14
10:56
07/14/20
10:56
MRNA

Moderna

$72.29 /

+0.57 (+0.79%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff reiterates an Overweight rating on Moderna with a $100 price target after the company posted the Phase III study protocol of its SARS-CoV-2 vaccine mRNA-1273 to clinicaltrials.gov this morning. The stock in morning trading is up 92c to $72.70. The study will randomize 30,000 Americans 18 years and older at high risk of infection to either 100ug mRNA-1273 or placebo intramuscular injections given on Day 1 and Day 29, Tenthoff tells investors in a research note. According to clinicaltrials.gov, the Phase III trial of mRNA-1273 is set to begin July 27, the analyst notes. Tenthoff says the Phase III trial is on track to start this month.

ShowHide Related Items >><<
MRNA Moderna
$72.29 /

+0.57 (+0.79%)

MRNA Moderna
$72.29 /

+0.57 (+0.79%)

07/13/20 Brookline
Moderna initiated with a Buy at Brookline
07/13/20 Jefferies
Jefferies starts Moderna with Buy rating, $90 price target
07/08/20 Piper Sandler
Piper reiterates $100 target on Moderna after Phase II study enrolled
07/02/20 BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
MRNA Moderna
$72.29 /

+0.57 (+0.79%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$72.29 /

+0.57 (+0.79%)

MRNA Moderna
$72.29 /

+0.57 (+0.79%)

MRNA Moderna
$72.29 /

+0.57 (+0.79%)

Syndicate
nCino indicated to open at $64, IPO priced at $31  10:55
07/14/20
07/14
10:55
07/14/20
10:55
NCNO

nCino

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 14
    Jul
NCNO nCino
$0.00 /

+ (+0.00%)

Periodicals
Amazon develops smart shopping cart Dash Cart, Bloomberg reports » 10:55
07/14/20
07/14
10:55
07/14/20
10:55
AMZN

Amazon.com

$3,038.33 /

-55.23 (-1.79%)

Amazon has developed a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,038.33 /

-55.23 (-1.79%)

AMZN Amazon.com
$3,038.33 /

-55.23 (-1.79%)

07:38 Today Oppenheimer
Walmart+ could better defend against Amazon grocery threat, says Oppenheimer
07/13/20 Cowen
Amazon.com price target raised to $3700 from $2750 at Cowen
07/13/20 Morgan Stanley
Morgan Stanley says Tesla's 'virtually unchallenged dominance' may be near end
07/13/20 Mizuho
Amazon.com price target raised to $3,450 from $3,100 at Mizuho
AMZN Amazon.com
$3,038.33 /

-55.23 (-1.79%)

AMZN Amazon.com
$3,038.33 /

-55.23 (-1.79%)

AMZN Amazon.com
$3,038.33 /

-55.23 (-1.79%)

AMZN Amazon.com
$3,038.33 /

-55.23 (-1.79%)

AMZN Amazon.com
$3,038.33 /

-55.23 (-1.79%)

Options
Splunk put volume heavy and directionally bearish » 10:55
07/14/20
07/14
10:55
07/14/20
10:55
SPLK

Splunk

$194.11 /

-3.99 (-2.01%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPLK Splunk
$194.11 /

-3.99 (-2.01%)

SPLK Splunk
$194.11 /

-3.99 (-2.01%)

06:28 Today Barclays
Splunk price target raised to $245 from $195 at Barclays
07/10/20 Morgan Stanley
Splunk price target raised to $246 from $172 at Morgan Stanley
07/10/20 BTIG
Splunk assumed with a Buy at BTIG
07/07/20 Rosenblatt
Splunk price target raised to $250 from $200 at Rosenblatt
SPLK Splunk
$194.11 /

-3.99 (-2.01%)

SPLK Splunk
$194.11 /

-3.99 (-2.01%)

SPLK Splunk
$194.11 /

-3.99 (-2.01%)

Conference/Events
UBS consumer services analysts hold an analyst/industry conference call » 10:55
07/14/20
07/14
10:55
07/14/20
10:55

Consumer Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
FDA briefing docs cite 'significant safety concern' for terlipressin » 10:54
07/14/20
07/14
10:54
07/14/20
10:54
MNK

Mallinckrodt

$2.62 /

-0.045 (-1.69%)

The Division of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNK Mallinckrodt
$2.62 /

-0.045 (-1.69%)

MNK Mallinckrodt
$2.62 /

-0.045 (-1.69%)

06/17/20 Citi
Sell Mallinckrodt, buy Endo with opioid risk coming back, says Citi
05/19/20 JPMorgan
Mallinckrodt downgraded to Underweight on unclear turnaround at JPMorgan
05/19/20 JPMorgan
Mallinckrodt downgraded to Underweight from Neutral at JPMorgan
04/24/20
Fly Intel: Top five analyst initiations
MNK Mallinckrodt
$2.62 /

-0.045 (-1.69%)

MNK Mallinckrodt
$2.62 /

-0.045 (-1.69%)

MNK Mallinckrodt
$2.62 /

-0.045 (-1.69%)

MNK Mallinckrodt
$2.62 /

-0.045 (-1.69%)

Hot Stocks
Citi CEO: World economy won't reach normalization without vaccine  10:53
07/14/20
07/14
10:53
07/14/20
10:53
C

Citi

$51.34 /

-0.91 (-1.74%)

 
ShowHide Related Items >><<
C Citi
$51.34 /

-0.91 (-1.74%)

C Citi
$51.34 /

-0.91 (-1.74%)

07/08/20 Seaport Global
Citi initiated with a Buy at Seaport Global
07/07/20 Societe Generale
Societe Generale upgrades BofA, Citi to Buy on 'path to respectability'
07/07/20 Societe Generale
Citi upgraded to Buy from Hold at Societe Generale
07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
C Citi
$51.34 /

-0.91 (-1.74%)

C Citi
$51.34 /

-0.91 (-1.74%)

C Citi
$51.34 /

-0.91 (-1.74%)

C Citi
$51.34 /

-0.91 (-1.74%)

Syndicate
nCino indicated to open at $62, IPO priced at $31  10:46
07/14/20
07/14
10:46
07/14/20
10:46
NCNO

nCino

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 14
    Jul
NCNO nCino
$0.00 /

+ (+0.00%)

Recommendations
Fox Factory down on Ford picking Bilstein for Bronco shocks, says Baird » 10:46
07/14/20
07/14
10:46
07/14/20
10:46
FOXF

Fox Factory

$73.33 /

-10.68 (-12.71%)

, F

Ford

$6.27 /

+0.195 (+3.21%)

Baird analyst Craig…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOXF Fox Factory
$73.33 /

-10.68 (-12.71%)

F Ford
$6.27 /

+0.195 (+3.21%)

FOXF Fox Factory
$73.33 /

-10.68 (-12.71%)

06/16/20 CJS Securities
Fox Factory downgraded to Market Perform from Outperform at CJS Securities
05/29/20
Fly Intel: Top five analyst upgrades
05/29/20 BofA
Fox Factory upgraded to Buy from Neutral at BofA
05/29/20 BofA
Fox Factory upgraded to Buy from Neutral at BofA
F Ford
$6.27 /

+0.195 (+3.21%)

06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/24/20 Morgan Stanley
GM electric vehicle business could be worth $100B, says Morgan Stanley
06/19/20 JPMorgan
Ford price target raised to $7 from $6 at JPMorgan
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
FOXF Fox Factory
$73.33 /

-10.68 (-12.71%)

F Ford
$6.27 /

+0.195 (+3.21%)

  • 18
    Jun
F Ford
$6.27 /

+0.195 (+3.21%)

FOXF Fox Factory
$73.33 /

-10.68 (-12.71%)

F Ford
$6.27 /

+0.195 (+3.21%)

F Ford
$6.27 /

+0.195 (+3.21%)

Options
HanesBrands call volume above normal and directionally bullish » 10:45
07/14/20
07/14
10:45
07/14/20
10:45
HBI

Hanesbrands

$12.30 /

+0.835 (+7.28%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HBI Hanesbrands
$12.30 /

+0.835 (+7.28%)

HBI Hanesbrands
$12.30 /

+0.835 (+7.28%)

10:11 Today
Fly Intel: Top five analyst upgrades
06:45 Today Credit Suisse
Hanesbrands upgraded to Outperform from Neutral at Credit Suisse
06:02 Today Credit Suisse
Hanesbrands upgraded to Outperform from Neutral at Credit Suisse
06/24/20 B. Riley FBR
Hanesbrands products largely sold out at Walmart and Target, says B. Riley FBR
HBI Hanesbrands
$12.30 /

+0.835 (+7.28%)

HBI Hanesbrands
$12.30 /

+0.835 (+7.28%)

HBI Hanesbrands
$12.30 /

+0.835 (+7.28%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.